...
首页> 外文期刊>Analytical Biochemistry: An International Journal of Analytical and Preparative Methods >Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions
【24h】

Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions

机译:膜联蛋白衍生物-红细胞膜相互作用的结合参数的测量

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Erythrocyte ghosts prepared from fresh blood expressed phosphatidylserine (PS) on the membrane surfaces in a rather stable fashion. The binding of fluorescein-5-isothiocyanate (FITC)-labeled annexin V (ANV) derivatives to these membranes was studied by titration with proteins and with calcium. Whereas the preaddition of ethylenediaminetetraacetic acid (EDTA) to reaction mixtures totally prevented membrane binding, Ca~(2+)-dependent binding was only partially reversed by EDTA treatment, consistent with an initial Ca~(2+)-dependent binding that became partially Ca~(2+) independent. Data derived from saturation titration with ANV derivatives poorly fit the simple protein-membrane equilibrium binding equation and showed negative cooperativity of binding with increasing membrane occupancy. In contrast, calcium titration at low binding site occupancy resulted in excellent fit into the protein-Ca~(2+)-membrane equilibrium binding equation. Calcium titrations of FITC-labeled ANV and ANV-6L15 (a novel ANV-Kunitz protease inhibitor fusion protein) yielded a Hill coefficient of approximately 4 in both cases. The apparent dissociation constant for ANV-6L15 was approximately 4-fold lower than that of ANV at 1.2-2.5mM Ca~(2+). We propose that ANV-6L15 may provide improved detection of PS exposed on the membrane surfaces of pathological cells in vitro and in vivo.
机译:由新鲜血液制备的红细胞幻影以相当稳定的方式在膜表面表达了磷脂酰丝氨酸(PS)。通过用蛋白质和钙滴定研究了荧光素5-异硫氰酸酯(FITC)标记的膜联蛋白V(ANV)衍生物与这些膜的结合。乙二胺四乙酸(EDTA)预先添加到反应混合物中完全阻止了膜结合,而EDTA处理只能使Ca〜(2+)依赖的结合部分逆转,这与最初的Ca〜(2+)依赖的结合成为部分Ca〜(2+)独立。用ANV衍生物饱和滴定法得到的数据不能很好地拟合简单的蛋白质-膜平衡结合方程,并且显示随着膜占有率的增加,结合的协同作用为负。相反,在低结合位点占有率下进行钙滴定可以很好地拟合蛋白质-Ca〜(2 +)-膜平衡结合方程。在两种情况下,FITC标记的ANV和ANV-6L15(新型ANV-Kunitz蛋白酶抑制剂融合蛋白​​)的钙滴定产生的Hill系数约为4。 ANV-6L15的表观解离常数比1.2-2.5mM Ca〜(2+)时的ANV低约4倍。我们建议ANV-6L15可以提供改进的体外和体内暴露于病理细胞膜表面的PS检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号